FDA-approved drug sensitises brain cancer cells to radiotherapy
Drug Discovery World
JANUARY 23, 2023
As an FDA-approved oral drug, the side-effects of cladribine are quite manageable and it has been well evaluated for pharmacokinetics. The post FDA-approved drug sensitises brain cancer cells to radiotherapy appeared first on Drug Discovery World (DDW).
Let's personalize your content